Matrix metalloproteinases 2 and 9 as diagnostic markers in the progression to Chagas cardiomyopathy

American Heart Journal

Volumn 165, Issue 4, 2013, Pages 558-566

  Bautista López, Norma Leticia ^a   Morillo, Carlos A ^b   López Jaramillo, Patricio ^c   Quiroz, Roberto ^d   Luengas, Carlos ^d   Silva, Sandra Y ^d   Galipeau, Jacques ^a,e   Lalu, Manoj Mathew ^f   Schulz, Richard ^g  

^a MCGILL UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^d FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^e EMORY UNIVERSITY   (United States)

^f OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE A; GELATINASE B;

ADULT; ARTICLE; CHAGAS DISEASE; COLOMBIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENSITOMETRY; DISEASE COURSE; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FEMALE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRYPANOSOMA CRUZI; ZYMOGRAPHY;

ADULT; ASYMPTOMATIC DISEASES; BIOLOGICAL MARKERS; CHAGAS CARDIOMYOPATHY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; TRYPANOSOMA CRUZI;

EID: 84875420235     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2013.01.001     Document Type: Article

References (44)

1. WHO Expert Committee Control of Chagas disease World Health Organ Tech Rep Ser 905 2002 1 109
2. J. Jannin, and R. Salvatella Quantitative estimates of Chagas disease in the Americas Pan Am Health Organ 2006 1 28 [OPS/HDM/CD/425-06]
3. C.M. Morel, and J. Lazdins Chagas' disease Nat Rev Microbiol 1 2003 14 15
4. F. Guhl, V. Angulo, and M. Restrepo Estado del arte de la enfermedad de Chagas en Colombia y estrategias de control Biomedica 23 2003 31 37
5. H. Acquatella Echocardiography in Chagas heart disease Circulation 115 2007 1124 1131
6. J.A. Marin-Neto, E. Cunha-Neto, and B.C. Maciel Pathogenesis of chronic Chagas heart disease Circulation 115 2007 1109 1123
7. A. Rassi Jr., A. Rassi, and S.G. Rassi Predictors of mortality in chronic Chagas disease: a systematic review of observational studies Circulation 115 2007 1101 1108
8. M.L. Higuchi, L.A. Benvenuti, and M.M. Reis Pathophysiology of the heart in Chagas' disease: current status and new developments Cardiovasc Res 60 2003 96 107
9. J. Rodrigues Coura, and S.L. de Castro A critical review on Chagas disease chemotherapy Mem Inst Oswaldo Cruz 97 2002 3 24
10. J. Rodrigues Coura, and V.P. Albajar Chagas disease: a new world wide problem Nature 465 2010 S6 S7
11. J. Clayton Chagas disease 101 Nature 465 2010 S4 S5
12. J. Clayton Chagas disease: pushing through the pipeline Nature 465 2010 S12 S15
13. J.A. Marin-Neto, A. Rassi Jr., and C.A. Morillo Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT) Am Heart J 156 2008 37 43
14. J.A. Marin-Neto, A. Rassi Jr., and A. Avezum Jr. The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease Men Inst Oswaldo Cruz 104 2009 319 324
15. L.S. Wilson, A.M. Strosberg, and K.L. Barrio Cost-effectiveness of Chagas disease interventions in Latin America and the Caribbean: Markov model Am J Trop Med Hyg 73 2005 901 910
16. C.D. Mathers, M. Ezzati, and A.D. Lopez Measuring the burden of neglected tropical diseases: the global burden of disease framework PLoS Negl Trop Dis 1 2007 e114
17. W. Savino, D.M. Villa-Verde, and D.A. Mendes-da-Cruz Cytokines and cell adhesion receptors in the regulation of immunity to Trypanosoma cruzi Cytokine Growth Factor Rev 18 2007 107 124
18. G. Murphy, and A. Gelatinase A.J. Barret, N.D. Rawlings, J.F. Woessner, Handbook of proteolitic enzymes 2004 Academic Press London 1199 1205
19. M. Egeblad, and Z. Werb New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 2002 61 174
20. Y. Kobayashi, M. Matsumoto, and M. Kotari Possible involvement of matrix metalloproteinase-9 in langerhans cell migration and maturation J Immunol 163 1999 5989 5993
21. J. Hu, P. Van den Steen, and Q.A. Sang Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases Nat Rev Drug Discov 6 2007 480 498
22. N.M. Hooper Families of zinc metalloproteinases FEBS Lett 354 1994 1 6
23. C.Q. Gao, G. Sawicki, and W.L. Suarez-Pinzon Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction Cardiovasc Res 57 2003 426 433
24. M.A. Ali, X. Fan, and R. Schulz Cardiac sarcomeric proteins: novel intracellular targets of matrix metalloproteinase-2 in heart disease Trends Cardiovasc Med 21 2011 112 118
25. L.M. Coussens, C.L. Tinkle, and D. Hanahan MMP-9 supplied by bone-derived cells contributes to skin carcinogenesis Cell 103 2000 481 490
26. F.G. Spinale Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function Physiol Rev 87 2007 1285 1342
27. M.L. Lindsey, J. Gannon, and M. Aikawa Selective matrix metalloproteinase inhibitions reduces left ventricular remodeling but does not inhibit angiogenesis after myocardial infarction Circulation 105 2002 753 758
28. P.Y. Cheung, G. Sawicki, and M. Wozniak Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart Circulation 101 2000 1833 1839
29. C. Marchesi, F. Dentali, and E. Nicolini Plasma levels of matrix metalloproteinases and their inhibitors in hypertension: a systematic review and meta-analysis J Hypertens 30 2012 3 16
30. L. Nilsson, J. Hallén, and D. Atar Early measurements of plasma matrix metalloproteinase-2 predict infarct size and ventricular dysfunction in ST-elevation myocardial infarction Heart 98 2012 31 36
31. H. Kitaoka, T. Kubo, and M. Okawa Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy Circ J 74 2010 1191 1196
32. S. Buralli, F.L. Dini, and P. Ballo Circulating matrix metalloproteinase-3 and metalloproteinase-9 and tissue Doppler measures of diastolic dysfunction to risk stratify patients with systolic heart failure Am J Cardiol 15 105 2010 853 856
33. J.M. Hagar, and S.H. Rahimtoola Chagas' heart disease Curr Prob Cardiol 20 1995 825 928
34. S.G. Andrade, J.A. Grimaud, and S. Stocker-Guerret Sequential changes of the connective matrix components of the myocardium (fibronectin and laminin) and evolution of cardiac fibrosis in mice infected with Trypanosoma cruzi Am J Trop Med Hyg 40 1989 252 260
35. F.R.S. Gutierrez, M.M. Lalu, and F.S. Mariano Increased activities of cardiac matrix metalloproteinases (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection J Infect Dis 197 2008 1468 1476
36. M.R. Zile, S.M. Desantis, and C.F. Baicu Plasma biomarkers that reflect determinants of matrix composition identify the presence of left ventricular hypertrophy and diastolic heart failure Circ Heart Fail 4 2011 246 256
37. Y. Noji, M. Shimizu, and H. Ino Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction Circ J 68 2004 355 360
38. V. Roldan, F. Marin, and J.R. Gimeno Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy Am Heart J 156 2008 85 91
39. R. Viotti, C. Vigliano, and B. Lococo Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial Ann Intern Med 144 2006 724 734
40. R. Aras, C. Bastos, and G. Mota Troponin in Chagas disease Braz J Infect Dis 7 2003 358 359
41. R. Schulz Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches Annu Rev Pharmacol Toxicol 47 2007 211 242
42. K.J. Leco, S.S. Apte, and G.T. Taniguchi Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues FEBS Lett 401 1997 213 217
43. C. Schulze, W. Wang, and W.L. Suarez-Pinzon Imbalance between tissue inhibitor of metalloproteinases-4 and matrix metalloproteinases during acute myocardial ischemia-reperfusion injury Circulation 107 2003 2487 2492
44. C.M. Tummalapalli, B.J. Heath, and S.C. Tyagi Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts J Cell Biochem 80 2001 512 521